Ascendis Pharma A/S Regulatory Update Transcript - Thomson StreetEvents

Ascendis Pharma A/S Regulatory Update Transcript

Ascendis Pharma A/S Regulatory Update Transcript - Thomson StreetEvents
Ascendis Pharma A/S Regulatory Update Transcript
Published May 01, 2023
9 pages (4895 words) — Published May 01, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ASND.OQ conference call or presentation 1-May-23 12:30pm GMT

  
Brief Excerpt:

...Operator Good day, ladies and gentlemen. Thank you for standing by. Welcome to Ascendis Pharma Regulatory Update Conference Call. (Operator Instructions) Please note that today's conference may be recorded. I will now hand the conference over to your speaker host, Tim Lee, Senior Director of Investor Relations. Please go ahead. Timothy J. Lee ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Ascendis Pharma A/S
Ticker
ASND.OQ
Time
12:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst : I have two, first, was manufacturing controls the only deficiency cited? And second, I think you mentioned no new preclinical nor Phase III studies were requested. Were any Phase I studies needed to back up the control strategy?

Question: Andreas Argyrides - Wedbush Securities Inc., Research Division - Analyst : Just a quick one from us What needs to be done prior to the Type A meeting? how can that speed up the process to getting there?

Question: Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst : Now that you have clarity on what the deficiency is, can you confirm whether or not you expect to need to pursue any further equity financing?

Table Of Contents

Ascendis Pharma A/S at Citi BioPharma Conference Transcript – 2023-09-07 – US$ 54.00 – Edited Transcript of ASND.OQ presentation 7-Sep-23 6:40pm GMT

Ascendis Pharma A/S Q2 2023 Earnings Call Transcript – 2023-09-05 – US$ 54.00 – Edited Transcript of ASND.OQ earnings conference call or presentation 5-Sep-23 8:30pm GMT

Ascendis Pharma A/S at Goldman Sachs Healthcare Conference Transcript – 2023-06-13 – US$ 54.00 – Edited Transcript of ASND.OQ presentation 13-Jun-23 4:20pm GMT

Ascendis Pharma A/S Oncology program update Transcript – 2023-05-31 – US$ 54.00 – Edited Transcript of ASND.OQ conference call or presentation 31-May-23 2:00pm GMT

Ascendis Pharma A/S at Bank of America Global Healthcare Conference Transcript – 2023-05-09 – US$ 54.00 – Edited Transcript of ASND.OQ presentation 9-May-23 3:40pm GMT

Ascendis Pharma A/S Q1 2023 Earnings Call Transcript – 2023-04-27 – US$ 54.00 – Edited Transcript of ASND.OQ earnings conference call or presentation 27-Apr-23 8:30pm GMT

Ascendis Pharma A/S Corporate Call Transcript – 2023-04-03 – US$ 54.00 – Edited Transcript of ASND.OQ conference call or presentation 3-Apr-23 12:30pm GMT

Ascendis Pharma A/S Q4 2022 Earnings Call Transcript – 2023-02-16 – US$ 54.00 – Edited Transcript of ASND.OQ earnings conference call or presentation 16-Feb-23 9:30pm GMT

Ascendis Pharma A/S at JPMorgan Healthcare Conference Transcript – 2023-01-09 – US$ 54.00 – Edited Transcript of ASND.OQ presentation 9-Jan-23 5:00pm GMT

Ascendis Pharma A/S Corporate Call Transcript – 2022-11-14 – US$ 54.00 – Edited Transcript of ASND.OQ conference call or presentation 14-Nov-22 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Ascendis Pharma A/S Regulatory Update Transcript" May 01, 2023. Alacra Store. May 04, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Ascendis-Pharma-A-S-Regulatory-Update-T15570169>
  
APA:
Thomson StreetEvents. (2023). Ascendis Pharma A/S Regulatory Update Transcript May 01, 2023. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Ascendis-Pharma-A-S-Regulatory-Update-T15570169>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.